benzimidazole

epidermal growth factor receptor ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34651438 Insights into the structure and drug design of benzimidazole derivatives targeting the epidermal growth factor receptor (EGFR). 2021 Oct 15 5
2 31009910 Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors. 2019 Jul 1 1
3 29571113 Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. 2018 Aug 1
4 27987485 Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors. 2017 Jan 27 2
5 26878127 Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent. 2016 Apr 1
6 25766325 A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells. 2015 Mar 12 1
7 25844392 Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole. 2014 Apr 9 2
8 22564276 Novel benzimidazole analogs as inhibitors of EGFR tyrosine kinase. 2012 Oct 1
9 21724404 Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors. 2011 Aug 1 3